{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:39:36Z","timestamp":1762501176106,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T00:00:00Z","timestamp":1652572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.afos.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:36:19Z","timestamp":1653608179000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of denosumab on renal function in women with osteoporosis evaluated using cystatin C"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6712-2278","authenticated-orcid":false,"given":"Tsuyoshi","family":"Ohishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotada","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"Murai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.afos.2022.05.002_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11657-018-0443-7","article-title":"Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review","volume":"13","author":"Fujiwara","year":"2018","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.afos.2022.05.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0773.1997.tb01964.x","article-title":"Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models","volume":"80","author":"Green","year":"1997","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.afos.2022.05.002_bib3","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jbmr.2058","article-title":"Renal safety in patients treated with bisphosphonates for osteoporosis: a review","volume":"28","author":"Miller","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2022.05.002_bib4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.afos.2022.05.002_bib5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.afos.2022.05.002_bib6","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.afos.2022.05.002_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00198-019-05228-8","article-title":"Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink","volume":"31","author":"Morley","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2022.05.002_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00198-019-04963-2","article-title":"Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study","volume":"30","author":"Borek","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2022.05.002_bib9","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2022.05.002_bib10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.clnu.2018.05.031","article-title":"Validation of the sarcopenia index to assess muscle mass in the critically ill: a novel application of kidney function markers","volume":"38","author":"Barreto","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.afos.2022.05.002_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2215\/CJN.02870707","article-title":"Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C","volume":"3","author":"Baxmann","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.afos.2022.05.002_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.afos.2022.05.002_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab safety and efficacy among participants in the FREEDOM extension study with mild to moderate chronic kidney disease","volume":"106","author":"Broadwell","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2022.05.002_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/jbmr.3821","article-title":"Denosumab improves glomerular filtration rate in osteoporotic patients with normal kidney function by lowering serum phosphorus","volume":"34","author":"Miyaoka","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2022.05.002_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","article-title":"Diagnostic criteria for primary osteoporosis: year 2000 revision","volume":"19","author":"Orimo","year":"2001","journal-title":"J\u00a0Bone Miner Metabol"},{"key":"10.1016\/j.afos.2022.05.002_bib16","first-page":"232","article-title":"Changes of bone mineral density and serum pentosidine during a 27-month follow-up of monthly minodronate in osteoporotic patients","volume":"42","author":"Ohishi","year":"2017","journal-title":"Endocr Res"},{"key":"10.1016\/j.afos.2022.05.002_bib17","first-page":"43","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"422","author":"Araki","year":"1987","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.afos.2022.05.002_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clinbiochem.2003.08.001","article-title":"A\u00a0sol particle homogeneous immunoassay for measuring serum cystatin C","volume":"37","author":"Tanaka","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.afos.2022.05.002_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.afos.2022.05.002_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am Kidney Dis"},{"key":"10.1016\/j.afos.2022.05.002_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.07.007","article-title":"Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan","volume":"61","author":"Horio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.afos.2022.05.002_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00776-009-1380-5","article-title":"Influence of the timing of surgery on mortality and activity of hip fracture in elderly patients","volume":"14","author":"Yonezawa","year":"2009","journal-title":"J\u00a0Orthop Sci"},{"key":"10.1016\/j.afos.2022.05.002_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chron Dis"},{"key":"10.1016\/j.afos.2022.05.002_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00198-019-05233-x","article-title":"Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates","volume":"31","author":"Miller","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2022.05.002_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.090716","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy","volume":"25","author":"Kendler","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2022.05.002_bib26","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1210\/jc.2016-1801","article-title":"Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates","volume":"101","author":"Miller","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2022.05.002_bib27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","article-title":"Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial","volume":"121","author":"Recknor","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.afos.2022.05.002_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2013.10.006","article-title":"Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study","volume":"58","author":"Roux","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.afos.2022.05.002_bib29","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1210\/jc.2019-00924","article-title":"Comparison of teriparatide and denosumab in patients switching from long-term bisphosphonate use","volume":"104","author":"Lyu","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2022.05.002_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12905-020-00913-x","article-title":"Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study","volume":"20","author":"Kobayashi","year":"2020","journal-title":"BMC Wom Health"},{"key":"10.1016\/j.afos.2022.05.002_bib31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.afos.2022.05.002_bib32","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jbmr.3138","article-title":"The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2-\u03b1]pyridin-3-yl)-ethyl-bisphosphonate)","volume":"32","author":"Lawson","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.afos.2022.05.002_bib33","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1515\/CCLM.2008.336","article-title":"Cystatin C: current position and future prospects","volume":"46","author":"S\u00e9ronie-Vivien","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.afos.2022.05.002_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/00365519609088586","article-title":"The effect of reduced glomerular filtration rate on plasma total homocysteine concentration","volume":"56","author":"Arnadottir","year":"1996","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.afos.2022.05.002_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","article-title":"Association between serum homocysteine and markers of impaired kidney function in adults in the United States","volume":"66","author":"Francis","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.afos.2022.05.002_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2008.193","article-title":"Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women","volume":"74","author":"Boonen","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.afos.2022.05.002_bib37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00198-019-04944-5","article-title":"Timeline of functional recovery after hip fracture in seniors aged 65 and older: a prospective observational analysis","volume":"30","author":"Fischer","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2022.05.002_bib38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12877-016-0332-0","article-title":"A\u00a0critical review of the long-term disability outcomes following hip fracture","volume":"16","author":"Dyer","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.afos.2022.05.002_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1359\/jbmr.080611","article-title":"Practical operationalizations of risk factors for fracture in older women: results from two longitudinal studies","volume":"24","author":"Pluijm","year":"2009","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525522000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525522000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:35:20Z","timestamp":1762500920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525522000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2405525522000255"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2022.05.002","relation":{},"ISSN":["2405-5255"],"issn-type":[{"type":"print","value":"2405-5255"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of denosumab on renal function in women with osteoporosis evaluated using cystatin C","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}